Javara to integrate industry-sponsored clinical trials at NC-based medical center

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Weedezign)
(Image: Getty/Weedezign)

Related tags: Clinical trial management, Clinical trial, Javara

After making waves with its launch in June, Javara this week has signed a letter of intent to design an operating model to integrate clinical trials at a medical center in Winston-Salem, NC.

Javara and Wake Forest Baptist Medical Center (WFBMC) will work together to make industry-sponsored clinical trials more accessible to WFBMC patients.

According to the company, which was launched earlier this year​, WFBMC leaders and Javara will work together over the next several months to define and launch an implementation strategy that will “more effectively engage patients in clinical research.”

Read: Connecting clinical trials to the health care ecosystem, and patients to better care

Terry G. Williams, executive vice president and chief strategy officer, WFBMC, in a press release said: “Wake Forest Baptist is committed to providing leading access to industry, NIH and other advanced clinical trials for truly exceptional and unparalleled care to our patients.”

The center’s newly solidified relationship with Javara is “a key step to expanding the impact of that commitment,” ​he explained.

Javara CEO Jennifer Byrne called the announcement “a milestone moment in healthcare and the clinical trial enterprise with Wake Forest Baptist Health.”

She added, “We look forward to navigating a new journey together in the mission to better integrate clinical research as an option within the continuum of care for patients.”

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more